Advertisement

Culture, Medicine, and Psychiatry

, Volume 38, Issue 2, pp 182–196 | Cite as

Promise and Deceit: Pharmakos, Drug Replacement Therapy, and the Perils of Experience

  • Todd Meyers
Original Paper

Abstract

The problem of lying as a feature of medication compliance has been well documented in anthropological and clinical literatures. Yet the role of the lie—its destabilizing effects on the continuity of drug treatment and therapy, as a technology of drug misuse, or as a way to understand the neuro-chemical processes of treatment (pharmacotherapy “tricking” or lying to the brain)—has been less considered, particularly in the context of opioid replacement therapy. The following paper is set against the backdrop of a three-year study of adolescents receiving a relatively new drug (buprenorphine) for the treatment of opiate dependency inside and outside of highly monitored treatment environments in the United States. Lies give order not only to the experience of addiction but also to the experience of therapy as well. In order to better understand this ordering of experience, the paper puts the widely discussed conceptual duality of the pharmakon (healing and poison) in conversation with a perilously overlooked subject in the critical study of pharmacotherapy, namely the pharmakos or the personification of sacrifice. The paper demonstrates how the patient-subject comes to represent therapeutic promise by allowing for the possibility of (and often performing) deceit.

Keywords

Addiction Adolescents Lies Pharmaceuticals United States 

Notes

Acknowledgments

I would like to thank Michael Oldani for his persistence in organizing this special issue of Culture, Medicine & Psychiatry; otherwise, I would have likely neglected the topic of lies for many more years. I appreciate the generous insights of Hermann Herlinghaus, particularly with helping me wrangle the tricky dimensions of pharmakos and its vast genealogy. I would also like to thank Annette Leibing, Johanne Collin, and the members of the MÉOS Research Group (Médicament comme Objet Social) at the Université de Montréal for their feedback on an earlier iteration of the paper. The paper benefited greatly from suggestions made by two anonymous readers. The majority of this research was conducted under a training fellowship from the National Institutes of Health/National Institute on Drug Abuse [F31-0202039—Sponsor: Dr. Jonathan M. Ellen, Johns Hopkins University, School of Medicine, Department of Pediatrics]. The Johns Hopkins University, Homewood Institutional Review Board approved the research [HIRB No. 2006021 “Therapeutic Contexts for Substance Abusing Adolescents”]. The names of the informants are pseudonyms.

References

  1. Biehl, João 2010 In Human Pharmakon: Symptoms, Technologies, Subjectivities, In A Reader in Medical Anthropology: Theoretical Trajectories, Emergent Realities. Byron Good, Michael M. J. Fischer, Sarah Willen, Mary-Jo Del Vecchio Good, eds., pp. 213–231 Malden, Boston: Wiley-Blackwell.Google Scholar
  2. Bok, Sissela 1978 Lying: Moral Choice in Public and Private Life. New York: Vintage.Google Scholar
  3. Campbell, Nancy D 2007 Discovering Addiction: The Science and Politics of Substance Abuse Research. Ann Arbor: University of Michigan Press.Google Scholar
  4. Campbell, Nancy D., and Anne M. Lovell 2012 The History of the Development of Buprenorphine as an Addiction Therapeutic. Annals of the New York Academy of Science 1248: 124–139.CrossRefGoogle Scholar
  5. Canguilhem, Georges (2012) Writings on Medicine, translated by Stefanos Geroulanos and Todd Meyers. New York: Fordham University Press.Google Scholar
  6. Center for Substance Abuse Treatment 2004 Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. Treatment Improvement Protocol (TIP) Series 40. DHHS Publication No. (SMA) 04-3939. Rockville, MD: Substance Abuse and Mental Health Services Administration.Google Scholar
  7. Conrad, Peter (1985) The Meaning of Medications: Another Look at Compliance. Social Science and Medicine 20(1): 29–37.CrossRefGoogle Scholar
  8. Courtwright, David T. 2001 Dark Paradise: A History of Opiate Addiction. Cambridge, MA: Harvard University Press.Google Scholar
  9. Crapanzano, Vincent (1992) Hermes’ Dilemma and Hamlet’s Desire: On the Epistemology of Interpretation. Cambridge: Harvard University Press.Google Scholar
  10. Dagognet, François (1964) La Raison et les remèdes. Paris: Presses Universitaires de France.Google Scholar
  11. Dagognet, François (1993) Deux sources, une seule lumière: comment et pourquoi?, In La philosophie de remède. Seyssel: Champ Vallon.Google Scholar
  12. Dagognet, François (2000) Complexité de la prescription médicamenteuse. In Les médecins doivent-ils prescrire des drogues? François Prevoteau, et al., eds., Paris: Presses Universitaires des France.Google Scholar
  13. Dagognet, François (2009) Pharmacology as a Physical Object, In French Studies in the Philosophy of Science. Jean Gayon, eds., Dordrecht: Springer.Google Scholar
  14. Dean, J.P., and W.F. Whyte (1958) How do you know if the informant is telling the truth? Human Organization 17 (2): 34–39.CrossRefGoogle Scholar
  15. Deleuze, Gilles (2006) Two Questions on Drugs, In Two Regimes of Madness: Texts and Interviews 1975-1995. New York: Semiotext(e).Google Scholar
  16. Derrida, Jacques (1981) Dissemination, translated by Barbara Johnson. Chicago: University of Chicago Press.Google Scholar
  17. Derrida, Jacques (2003) The Rhetoric of Drugs, In High Culture: Reflections on Addiction and Modernity, edited by Anna Alexander and Mark S. Roberts. Albany, N.Y.: State University of New York.Google Scholar
  18. Erickson, Carlton K.(2007) The Science of Addiction: From Neurobiology to Treatment. New York: W.W. Norton and Company.Google Scholar
  19. Fainzang, Sylvie (2002) Lying, Secrecy, and Power within the Doctor-Patient Relationship. Anthropology and Medicine 9 (2): 117-133.CrossRefGoogle Scholar
  20. Fainzang, Sylvie (2007) Anthropology and Medicine: Empathy, Experience and Knowledge, In Facing Distress and Proximity in Times of Illness, edited by Els van Dongen and Ruth Kutalek. Wien: Wiener Ethnomedizinische Reine, Bd.Google Scholar
  21. Fairer, J. G.(2006) Optimistic Lies. British Medical Journal 332(7551): 1212.CrossRefGoogle Scholar
  22. Foucault, Michel (2006) History of Madness, translated by Jonathan Murphy. London: Routledge.Google Scholar
  23. Greene, Jeremy A. (2004) Therapeutic Infidelities: Noncompliance Enters the Medical Literature: 1955-1975. Social History of Medicine 17 (3): 327-343.CrossRefGoogle Scholar
  24. Girard, René 1977 Violence and the Sacred. Baltimore: Johns Hopkins University Press.Google Scholar
  25. Girard, René (1986) The Sacrifice, translated by Yvonne Freccero. Baltimore: Johns Hopkins University Press.Google Scholar
  26. Herlinghaus, Hermann (2013) Narcoepics: A Global Aesthetics of Sobriety. London: Bloomsbury Academic.Google Scholar
  27. Hubert, Henri, and Marcel Mauss (1964) Sacrifice: Its Nature and Function, translated by W. D. Halls. Chicago: University of Chicago Press.Google Scholar
  28. Le Poulichet, Sylvie (2011) L’addiction est un traitement de substitution. L’évolution psychiatrique 76 (3): 485-491.CrossRefGoogle Scholar
  29. Lovell, Anne M. (2006) Addiction Markets: The Case of High-Dose Buprenorphine in France. In Global Pharmaceuticals: Ethics, Markets, Practices, edited by A. Petryna, A. Lakoff, and A. Kleinman. Durham: Duke University Press.Google Scholar
  30. Malinowski, Bronislaw (1967) A Diary in the Strict Sense of the Term. New York: Harcourt, Brace and World.Google Scholar
  31. Martin, Emily (2006) The Pharmaceutical Person. BioSocieties 1: 273-287.CrossRefGoogle Scholar
  32. Massé, Raymond (2002) Gadè Deceptions and Lies told by the Ill: The Caribbean Socio-Cultural Construction of Truth in Patient-Healer Encounters. Anthropology and Medicine 9 (2): 175-188.CrossRefGoogle Scholar
  33. Meyers, Todd (2013) The Clinic and Elsewhere: Addiction, Adolescents, and the Afterlife of Therapy. Seattle: University of Washington Press.Google Scholar
  34. Nietzsche, Friedrich (1967) The Will to Power, translated by Walter Kaufman. New York: Vintage.Google Scholar
  35. Page, Carl (1991) The Truth about Lies in Plato’s Republic. Ancient Philosophy 11 (1): 1-33.CrossRefGoogle Scholar
  36. Palmieri, John J., and Theodore A. Stern (2009) Lies in the Doctor-Patient Relationship. Primary Care Companion Journal of Clinical Psychiatry 11 (4): 163-168.CrossRefGoogle Scholar
  37. Plato (2005) Phaedrus, translated by Christopher Rowe. New York: Penguin Classics.Google Scholar
  38. Rinella, Michael A. (2010) Pharmakon: Plato, Drug Culture, and Identity in Ancient Athens. New York: Lexington Books.Google Scholar
  39. Salamone, Frank A. (1977) The Methodological Significance of the Lying Informant. Anthropological Quarterly 50 (3): 117-124.CrossRefGoogle Scholar
  40. Schüll, Natasha Dow (2006) Machines, Medication, Modulation: Circuits of Dependency and Self-Care in Las Vegas. Culture, Medicine, & Psychiatry 30 (2): 223-247.CrossRefGoogle Scholar
  41. Smyth, John Vignaux (2002) The Habit of Lying: Sacrificial Studies in Literature, Philosophy, and Fashion Theory. Durham: Duke University Press.CrossRefGoogle Scholar
  42. Sontag, Deborah 2013 The Double-Edged Drug: Addiction Treatment with a Dark Side. The New York Times, November 16, 2013.Google Scholar
  43. van Dongen, Els (2002) Theatres of the Lie: “Crazy” Deception and Lying as Drama. Anthropology and Medicine 9 (2): 135-151.CrossRefGoogle Scholar
  44. van Dongen, Els, and Sylvie Fainzang (2002) Lying, Misery, and Illness: Towards a Medical Anthropology of the Lie. Anthropology and Medicine 9 (2): 85-95.CrossRefGoogle Scholar
  45. Vernant, Jean-Pierre (1980) Myth and Society in Ancient Greece, translated by Janet Lloyd. Atlantic Highlands, N.J.: Harvester Press.Google Scholar
  46. Vernant, Jean-Pierre, and Pierre Vidal-Naquet (1988) Myth and Tragedy in Ancient Greece, translated by Janet Lloyd. New York: Zone Books.Google Scholar
  47. Wolf-Meyer, Matthew (2009) Precipitating Pharmakologies and Capital Entrapments: Narcolepsy and the Strange Cases of Provigil and Xyrem. Medical Anthropology 28 (1): 11-30.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Department of AnthropologyWayne State UniversityDetroitUSA

Personalised recommendations